Literature DB >> 19081537

Chick embryo chorioallantoic membrane as a useful tool to study angiogenesis.

Domenico Ribatti1.   

Abstract

The chick embryo chorioallantoic membrane (CAM) is an extraembryonic membrane mediating gas and nutrient exchanges until hatching. Since it has a dense capillary network, it has been commonly used in vivo to study both angiogenesis and antiangiogenesis in response to normal tissues and cells, to tumor bioptic specimens and cells, or to soluble factors. During the last 8 years, this assay has been used in over 550 published works. This chapter summarizes current knowledge about the embryological origin of the CAM, morphology of its blood and lymphatic vessels, the use of CAM in the study of tumor angiogenesis and metastasis, angiogenic and antiangiogenic substances. The angiogenic response of CAM to multiple myeloma and neuroblastoma cells and bioptic specimens and their responses to antiangiogenic molecules and the role played by fibroblast growth factor-2 in CAM vascularization have been analyzed in detail. Finally, advantages and limitations of CAM as an experimental model to study angiogenesis and antiangiogenesis are discussed.

Entities:  

Mesh:

Year:  2008        PMID: 19081537     DOI: 10.1016/S1937-6448(08)01405-6

Source DB:  PubMed          Journal:  Int Rev Cell Mol Biol        ISSN: 1937-6448            Impact factor:   6.813


  46 in total

1.  Inhibition of angiogenesis by a novel neutralizing antibody targeting human VEGFR-3.

Authors:  Hao Chen; Xiuyun Ding; Yuan Gao; Xiaohua Jiang; Xiaolan Liu; Yong Chen; Jianen Gao; Xiaping Zhou; Zhiming Cai; Qihong Sun
Journal:  MAbs       Date:  2013-08-22       Impact factor: 5.857

2.  45S5-Bioglass(®)-based 3D-scaffolds seeded with human adipose tissue-derived stem cells induce in vivo vascularization in the CAM angiogenesis assay.

Authors:  Marina Handel; Timo R Hammer; Patcharakamon Nooeaid; Aldo R Boccaccini; Dirk Hoefer
Journal:  Tissue Eng Part A       Date:  2013-08-12       Impact factor: 3.845

3.  Photoacoustic microscopy: a potential new tool for evaluation of angiogenesis inhibitor.

Authors:  Sung-Liang Chen; Joseph Burnett; Duxin Sun; Xunbin Wei; Zhixing Xie; Xueding Wang
Journal:  Biomed Opt Express       Date:  2013-10-25       Impact factor: 3.732

Review 4.  The chick chorioallantoic membrane (CAM) as a versatile patient-derived xenograft (PDX) platform for precision medicine and preclinical research.

Authors:  Logan C DeBord; Ravi R Pathak; Mariana Villaneuva; Hsuan-Chen Liu; Daniel A Harrington; Wendong Yu; Michael T Lewis; Andrew G Sikora
Journal:  Am J Cancer Res       Date:  2018-08-01       Impact factor: 6.166

5.  Molecular cloning, sequence characterization, and tissue expression analysis of Hi-Line Brown chicken Akirin2.

Authors:  Chaolai Man; Xiang Li; Jongeun Lee
Journal:  Protein J       Date:  2011-10       Impact factor: 2.371

6.  Natalizumab reduces serum pro-angiogenic activity in MS patients.

Authors:  Pietro Iaffaldano; Domenico Ribatti; Maria Trojano
Journal:  Neurol Sci       Date:  2018-02-13       Impact factor: 3.307

Review 7.  The chick chorioallantoic membrane: a model of molecular, structural, and functional adaptation to transepithelial ion transport and barrier function during embryonic development.

Authors:  Maria Gabriella Gabrielli; Daniela Accili
Journal:  J Biomed Biotechnol       Date:  2010-03-21

8.  Gene signatures in wound tissue as evidenced by molecular profiling in the chick embryo model.

Authors:  Fabienne Soulet; Witold W Kilarski; Philipp Antczak; John Herbert; Roy Bicknell; Francesco Falciani; Andreas Bikfalvi
Journal:  BMC Genomics       Date:  2010-09-14       Impact factor: 3.969

9.  Chick ex ovo culture and ex ovo CAM assay: how it really works.

Authors:  Daniel S Dohle; Susanne D Pasa; Sebastian Gustmann; Markus Laub; Josef H Wissler; Herbert P Jennissen; Nicole Dünker
Journal:  J Vis Exp       Date:  2009-11-30       Impact factor: 1.355

10.  First evidence of in vivo pro-angiogenic activity of cerebrospinal fluid samples from multiple sclerosis patients.

Authors:  Domenico Ribatti; Pietro Iaffaldano; Christian Marinaccio; Maria Trojano
Journal:  Clin Exp Med       Date:  2014-12-25       Impact factor: 3.984

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.